{"transactions":[{"id":2432227,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-19T16:36:06.000Z","date":"2022-01-16","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest ratably on a monthly basis over four years with the first vesting date to occur on February 28, 2022 and on the last day of each month thereafter."}],"balance_after":70000,"derivative":{"exercise_price":6.25,"expiration_date":"2032-01-16","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-22-005473","document":"tm221559-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465922005473/tm221559-6_4seq1.xml","form_type":"4"}},{"id":2432226,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Restricted Stock Units","published_at":"2022-01-19T16:36:06.000Z","date":"2022-01-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the RSUs shall vest on February 28, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the RSUs shall vest on February 28, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-22-005473","document":"tm221559-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465922005473/tm221559-6_4seq1.xml","form_type":"4"}},{"id":2515032,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Performance Stock Units","published_at":"2021-11-12T21:03:49.000Z","date":"2021-11-10","kind":"grant","acquired":false,"shares":51250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (PSU) converts into one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 19, 2021, the reporting person was granted 51,250 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 19, 2021, the reporting person was granted 51,250 PSUs, vesting in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":51250},"source":{"system":"sec-edgar","filing":"0001104659-21-138343","document":"tm2132597-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921138343/tm2132597-6_4seq1.xml","form_type":"4"}},{"id":2515031,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2021-11-12T21:03:49.000Z","date":"2021-11-12","kind":"tax_withholding","acquired":false,"shares":11882,"price":4.8985,"value":58203.977,"ownership":{"direct":true},"balance_after":38881,"source":{"system":"sec-edgar","filing":"0001104659-21-138343","document":"tm2132597-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921138343/tm2132597-6_4seq1.xml","form_type":"4"}},{"id":2515030,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2021-11-12T21:03:49.000Z","date":"2021-11-12","kind":"tax_withholding","acquired":false,"shares":487,"price":5.045,"value":2456.915,"ownership":{"direct":true},"balance_after":50763,"source":{"system":"sec-edgar","filing":"0001104659-21-138343","document":"tm2132597-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921138343/tm2132597-6_4seq1.xml","form_type":"4"}},{"id":2515029,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2021-11-12T21:03:49.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":51250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance stock unit (PSU) converts into one share of common stock of the Issuer."}],"balance_after":51250,"source":{"system":"sec-edgar","filing":"0001104659-21-138343","document":"tm2132597-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921138343/tm2132597-6_4seq1.xml","form_type":"4"}},{"id":2625854,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-23T18:15:18.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861."}],"balance_after":10000,"derivative":{"exercise_price":2.54,"expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-21-095512","document":"tm2123135-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921095512/tm2123135-7_4seq1.xml","form_type":"4"}},{"id":2902297,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Performance Stock Units","published_at":"2021-01-20T20:19:24.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":51250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for\nLIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for\nLIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":51250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":51250},"source":{"system":"sec-edgar","filing":"0001104659-21-005981","document":"tm213622-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921005981/tm213622-1_4seq1.xml","form_type":"4"}},{"id":2902296,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-20T20:19:24.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":102500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over a four-year period, becoming fully vested on January 19, 2025."}],"balance_after":102500,"derivative":{"exercise_price":2.97,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":102500},"source":{"system":"sec-edgar","filing":"0001104659-21-005981","document":"tm213622-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465921005981/tm213622-1_4seq1.xml","form_type":"4"}},{"id":3142656,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":131280,"kind":"person","name":"Shah Tushar","position":1,"cik":"0001487632","reported_name":"Shah Tushar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Oficer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-19T16:40:21.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on May 18, 2024."}],"balance_after":230000,"derivative":{"exercise_price":7.95,"exercise_date":"2021-05-18","expiration_date":"2030-05-18","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001104659-20-063810","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487632/000110465920063810/a4.xml","form_type":"4"}}]}